| Sarcoma Diagnosis and Treatment | Lifetime | 26 | NL 2 | 99.81 |
| Bone Tumor Diagnosis and Treatments | Lifetime | 20 | NL 3 | 99.72 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 10 | NL 2 | 99.71 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 43 | NL 2 | 99.64 |
| Vascular Tumors and Angiosarcomas | Lifetime | 32 | NL 2 | 99.46 |
| Cancer Treatment and Pharmacology | Lifetime | 184 | NL 6 | 99.43 |
| Colorectal Cancer Treatments and Studies | Lifetime | 206 | NL 10 | 99.28 |
| Gastric Cancer Management and Outcomes | Lifetime | 362 | NL 22 | 99.15 |
| Gastrointestinal disorders and treatments | Lifetime | 255 | NL 7 | 98.89 |
| Cardiac tumors and thrombi | Lifetime | 130 | NL 4 | 98.63 |
| Cancer therapeutics and mechanisms | Lifetime | 242 | NL 9 | 98.61 |
| Neutropenia and Cancer Infections | Lifetime | 221 | NL 11 | 97.87 |
| Virus-based gene therapy research | Lifetime | 909 | NL 22 | 97.66 |
| Animal Virus Infections Studies | Lifetime | 611 | NL 27 | 97.36 |
| Pharmacogenetics and Drug Metabolism | Lifetime | 592 | NL 19 | 96.83 |
| Oral and Maxillofacial Pathology | Lifetime | 836 | NL 21 | 96.34 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 778 | NL 21 | 96.80 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 446 | NL 4 | 95.65 |
| Multiple Myeloma Research and Treatments | Lifetime | 980 | NL 22 | 95.54 |
| Chemotherapy-related skin toxicity | Lifetime | 202 | NL 9 | 93.44 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 876 | NL 15 | 93.98 |
| Soft tissue tumors and treatment | Lifetime | 136 | NL 6 | 92.22 |
| Musculoskeletal synovial abnormalities and treatments | 2021-2025 | 1 | NL 1 | 99.84 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 5 | NL 1 | 99.73 |
| Bone Tumor Diagnosis and Treatments | 2021-2025 | 3 | NL 2 | 99.44 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 19 | NL 1 | 99.25 |
| Gastrointestinal disorders and treatments | 2021-2025 | 26 | NL 2 | 98.04 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 159 | NL 10 | 98.33 |
| Cancer Genomics and Diagnostics | 2021-2025 | 406 | NL 12 | 97.28 |
| Cardiac tumors and thrombi | 2021-2025 | 45 | NL 4 | 95.50 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 34 | NL 3 | 95.48 |
| Neurofibromatosis and Schwannoma Cases | 2021-2025 | 375 | NL 8 | 83.74 |
| Estrogen and related hormone effects | 2021-2025 | 585 | NL 19 | 77.69 |
| Statistical Methods in Clinical Trials | 2021-2025 | 996 | NL 46 | 66.13 |
| Soft tissue tumors and treatment | 2021-2025 | 79 | NL 1 | 61.65 |
| Plant and Fungal Interactions Research | 2021-2025 | 900 | NL 7 | 61.52 |
